Open in interactive viewer → charts, metric popovers & call review

Swiss Life's 205% Solvency Print Comes With a Footnote Nobody Asked For

The top line was fine. The interesting news is that Swiss Life is quietly inventing a new sensitivity table for the thing that keeps eating its capital.
SLHN.SW · Earnings Call · 2026-11-11

The number was good; the composition was the story

Swiss Life's nine-month update looked like a Swiss insurer doing Swiss insurer things: fee and commission income up 8% in local currency past CHF 2 billion, gross written premiums up 8% to CHF 17.4 billion, and a Swiss division that grew premiums 15% against a market that grew 4%. Net new assets in third-party asset management came in at CHF 8.5 billion against an extraordinary CHF 15 billion prior-year comparison, with CHF 2.2 billion of that in real assets — real estate and infrastructure, the high-fee stuff. Assets under management climbed from CHF 146 billion at year-end 2025 to CHF 161 billion. All fine. But the figure that did the work on this call was the SST ratio, estimated at around 205% at end-September, roughly 10 percentage points below the June level. And unusually, management chose to decompose it in public detail: almost half from two deliberate business decisions — the CHF 250 million buyback deduction and the TELIS goodwill, which is simply not eligible capital under SST — about a third from adverse markets, and the remainder from lapse and the ultimate forward rate cut. That decomposition is not a disclosure accident. It is an argument. The argument is: the solvency dip is mostly self-inflicted by capital return and M&A, not by portfolio rot. Read against the prior quarter, though, it reads differently.

The rate differential graduates from footnote to feature

Back in September, JPMorgan's David Barma asked about the CHF/USD rate differential and the CSM and SST. Marco Gerussi's answer was a shrug: “The differential was just the marginal one of the very, very let's say, there are many smaller items moving a bit up and then the down, but that is not, let's say, an unmanageable impact on the numbers.” — Marco Gerussi, Group CFO · 2026-05-21 Not nothing, but not a headline. Three months later the rate differential is the single highest-momentum keyword in Swiss Life's entire vocabulary — and the CEO is volunteering to build it a permanent home in the disclosure pack:

We appreciate the fact that there is some questions every now and then around the impact of those interest rate differentials, and we're considering to introduce, let's say, a meaningful sensitivity around interest rate differential for the full year disclosure... it's about the differential at long maturities. So, let's say, at 10 years or something like that. That's what is driving this sensitivity.

Matthias Aellig, CEO · 2026-11-11
Companies do not build sensitivity tables for immaterial risks. They build them when the sell side will not stop asking, which is precisely what happened on this call — Barma tried twice to pin down magnitude, and got "around a third of it is market movements" without ever getting a number. Widening CHF–USD spreads plus higher French government bond spreads did the damage, and the second one is the part that matters for the real estate book. The second genuinely new item is lapse experience, which was not previously a ranked theme for this name. Gerussi was careful to explain that the lapse strain is a framework artefact as much as a behaviour change: “In IFRS, there is a policyholder mitigation in the participating business. In SST, there is not.” — Marco Gerussi, Group CFO · 2026-11-11 Lapses rose in French and German products, in line with the market, and the models now carry it. Nothing alarming — but it is the one line item in the SST walk that is neither a chosen capital action nor a market mark.

Two chapters closing quietly

The BVG rate hike is the fresh external shock. The Federal Council lifted the minimum guaranteed rate from 1.25% to 2%, and Aellig — mindful that CHF 16.5 billion of technical reserves sit on that rate, against CHF 68 billion of total Group Life reserves — was almost ostentatiously relaxed: “In practice, if I look into the day-to-day management of the business, we do not expect that to be a relevant, let's say, restriction. However, in the SST, it has a certain impact.” — Matthias Aellig, CEO · 2026-11-11 Running yield of about 2% versus a guarantee averaging near 1% means the BVG business is comfortably above the legal quote. Fine. But note the analytical consequence René Locher of Oddo pulled out: if the new guarantee does not bind, it also cannot unlock anything. “The reserve releases never related to the old age savings account that is now subject to the minimum guaranteed rate... we never had any reserve release from the old age annuities. So the short answer is no, there's no correlation with that.” — Marco Gerussi, Group CFO · 2026-11-11 That is a quiet but real change in the equity story. Reserve release was a pillar of this company's capital narrative for years — it sat near the top of the keyword deck in 2024 and 2025, with management anchoring a CHF 0.3 billion run rate back in September 2024: “For the full year, that was then CHF 0.3 billion, which like then we said is the run rate, and which we say for the full year that CHF 0.3 billion is also the run rate that we see in the current interest rate environment.” — Matthias Aellig, Chief Executive Officer · 2024-09-03 That lever has now been formally decoupled from the BVG discussion. It has not been repudiated — but it has stopped being a live topic, and the questions about it have been answered rather than explored. When a management team stops talking about something it used to foreground, that is information.

The capital return stalemate, round four

The buyback policy discussion is now ritual. Michael Huttner and Farooq Hanif both pressed on the same thing: holdco liquidity has fallen from CHF 1.1 billion at the half year to CHF 650 million, because a CHF 500 million bond was partly spent on the acquisition of TELIS and the rest pushed down to the divisions. The CHF 250 million buyback runs to end-March 2027 with only CHF 54 million repurchased by 9 November. Consensus logic says higher solvency plus comfortable holdco equals more buyback; management says, as it said in September, in May, and back in 2024, that there is no automatism. “So there's actually nothing new that we can talk about and just confirm what we said at the Investors Day last time... Nothing has changed in terms of the buyback policy.” — Matthias Aellig, CEO · 2026-11-11 The tell is in the size and shape: a six-month, CHF 250 million programme is smaller and shorter than the historical pattern, and the explanation is a holdco constraint that management simultaneously describes as a comfort range and as binding. Both can be true. But the market is being asked to accept that a company with a 205% SST ratio is capital-constrained — and the December 2027 Investor Day is now the only date at which that assumption can be tested.

What Swiss Life is not

Worth stating plainly: none of the global market's dominant themes touch this call. No tariffs, no AI capital expenditure, no Fed cycle, no data-centre power. The one incidental intersection is old age provision and the German pension reform, and even there management was careful to point out that the 2027 reform slows the private-provision business in H2 2026 before it opens an advisory opportunity in 2027. Among the insurers reporting this week, the shared language was P&C loss trend and favourable prior-year development — a different genre of reserve conversation entirely. So this is a company-specific dossier. The premium growth is real, the fee engine is compounding, and the French unit-linked share of 72% against a market average of 39% remains the quiet quality marker. But the three things actually moving the needle this quarter — the rate differential, lapse modelling, and the BVG guarantee — all point the same direction: Swiss Life's capital generation is becoming more sensitive to long-end spreads and policyholder behaviour, just as it becomes more reluctant to convert that capital into distributions. That tension, not the CHF 17.4 billion of premiums, is the one to watch into the full year.